Neurocrine Biosciences (NBIX) Shares Repurchased (2024 - 2026)

Neurocrine Biosciences has reported Shares Repurchased for 3 years, with the latest figure at $54.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Repurchased fell 64.0% year-over-year to $54.0 million; the trailing twelve-month figure through Mar 2026 stood at $71.7 million (down 84.07% YoY), and the FY2025 full-year result was $167.7 million, down 44.1% from the prior year.
• Shares Repurchased for Q1 2026 stood at $54.0 million, up from $17.7 million in the prior quarter.
• The five-year high for Shares Repurchased was $300.0 million in Q4 2024, with the low at $17.7 million in Q2 2025.
• Historically, Shares Repurchased has averaged $130.4 million across 3 years, with a median of $102.0 million in 2025.
• The largest YoY upside for Shares Repurchased was 64.0% in 2026 against a maximum downside of 64.0% in 2026.
• Neurocrine Biosciences' Shares Repurchased stood at $300.0 million in 2024, then plunged by 94.1% to $17.7 million in 2025, then surged by 205.08% to $54.0 million in 2026.
• The last three Shares Repurchased figures came in at $54.0 million (Q1 2026), $17.7 million (Q2 2025), and $150.0 million (Q1 2025), per Business Quant data.